Pancreatic cancer tumours vanish in promising clinical trial
Health Desk
A new treatment for pancreatic cancer, involving the KRAS inhibitor Daraxonrasib, has demonstrated the ability to cause tumours to disappear in clinical trials. Dr Wungki Park of the Memorial Sloan Kettering Cancer Center in the US, who is participating in the research, described the current findings as extremely encouraging.
Advertisement
Daraxonrasib functions by identifying and deactivating specific RAS mutations that facilitate tumour development in the majority of pancreatic cancer cases. This medication has already received approval for use in the US. Experts believe the treatment could potentially benefit patients with other forms of the disease, such as lung and ovarian cancer, which often share these mutations.
Regarding the trial's progress, Dr Wungki Park stated, "We are beginning to see not only a higher percentage of tumour response rates, but also deeper responses and a near doubling in the duration of disease control, which may eventually translate into longer survival."
Prof Elena Garralda, who chairs the EORTC European cancer conference where the findings are being shared, remarked that the combined approach could significantly enhance overall survival times. However, Dr Godfrey warned that further research is necessary, noting: "I would hope that the early success that we are beginning to see in pancreatic cancer can also be rolled out to other cancers."
Dr Godfrey added a note of caution, stating: "Cancer can come back and even if scans show there is no sign of it, you don't necessarily know you are cancer-free until more time has passed." Statistics from Cancer Research UK indicate that there are 11,500 annual diagnoses of the disease in Britain, resulting in approximately 10,200 deaths. The actor Alan Rickman passed away from pancreatic cancer in 2016, just five months after he was diagnosed.
Advertisement
Common symptoms associated with the condition include tiredness, unexplained weight loss, jaundice, itchy skin, a high temperature, darker urine and paler stools.